Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Engel W. K., McFarlin D. E. Muscle lesions in myasthenia gravis. Discussion. Ann N Y Acad Sci. 1966 Jan 26;135(1):68–78. doi: 10.1111/j.1749-6632.1966.tb45464.x. [DOI] [PubMed] [Google Scholar]
- FENICHEL G. M., SHY G. M. MUSCLE BIOPSY EXPERIENCE IN MYASTHENIA GRAVIS. Arch Neurol. 1963 Sep;9:237–243. doi: 10.1001/archneur.1963.00460090043004. [DOI] [PubMed] [Google Scholar]
- Feltkamp T. E., van Rossum A. L. Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases. Clin Exp Immunol. 1968 Jan;3(1):1–16. [PMC free article] [PubMed] [Google Scholar]
- Fenichel G. M. Muscle lesions in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):60–67. doi: 10.1111/j.1749-6632.1966.tb45463.x. [DOI] [PubMed] [Google Scholar]
- Goldstein G. Thymitis and myasthenia gravis. Lancet. 1966 Nov 26;2(7474):1164–1167. doi: 10.1016/s0140-6736(66)90479-x. [DOI] [PubMed] [Google Scholar]
- Henry K. Mucin secretion and striated muscle in the human thymus. Lancet. 1966 Jan 22;1(7430):183–185. doi: 10.1016/s0140-6736(66)90703-3. [DOI] [PubMed] [Google Scholar]
- McFarlin D. E., Engel W. K., Strauss A. J. Does myasthenic serum bind to the neuromuscular junction? Ann N Y Acad Sci. 1966 Jan 26;135(1):656–663. doi: 10.1111/j.1749-6632.1966.tb45512.x. [DOI] [PubMed] [Google Scholar]
- Oosterhuis H. J., van der Geld H., Gfeltkamp T. E. Studies in myasthenia gravis. 2. The relation of some clinical and immunological data. J Neurol Sci. 1967 May-Jun;4(3):417–434. doi: 10.1016/0022-510x(67)90027-5. [DOI] [PubMed] [Google Scholar]
- ROWLAND L. P., HOEFER P. F., ARANOW H., Jr, MERRITT H. H. Fatalities in myasthenia gravis; a review of 39 cases with 26 autopsies. Neurology. 1956 May;6(5):307–326. doi: 10.1212/wnl.6.5.307. [DOI] [PubMed] [Google Scholar]
- RUSSELL D. S. Histological changes in the striped muscles in myasthenia gravis. J Pathol Bacteriol. 1953 Apr;65(2):279–289. doi: 10.1002/path.1700650202. [DOI] [PubMed] [Google Scholar]
- Strauss A. J., Kemp P. G., Douglas S. D. Myasthenia gravis. Lancet. 1966 Apr 2;1(7440):772–773. doi: 10.1016/s0140-6736(66)90931-7. [DOI] [PubMed] [Google Scholar]
- Strauss A. J., Smith C. W., Cage G. W., van der Geld H. W., McFarlin D. E., Barlow M. Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications. Ann N Y Acad Sci. 1966 Jan 26;135(1):557–579. doi: 10.1111/j.1749-6632.1966.tb45504.x. [DOI] [PubMed] [Google Scholar]
- VAN DER GELD H., FELTKAMP T. E., VAN LOGHEM J., OOSTERHUIS H. J., BIEMOND A. MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS. Lancet. 1963 Aug 24;2(7304):373–375. doi: 10.1016/s0140-6736(63)93055-1. [DOI] [PubMed] [Google Scholar]
- de Vries M. J., Hijmans W. Pathological changes of thymic epithelial cells and autoimmune disease in NZB, NZW and (NZB x NZW)F1 mice. Immunology. 1967 Feb;12(2):179–196. [PMC free article] [PubMed] [Google Scholar]